aluates Reports

$ 0.0

Automative

Global NGAL Antibody Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-32A18482

BUY CHAPTERS

Global NGAL Antibody Market Research Report 2024

Code: QYRE-Auto-32A18482

Report

November 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Abcam

Hytest

Enzo Life Sciences

Biorbyt

Proteintech

Biomatik

Bio-Techne

MyBioSource

GenScript

Bioss

BioNC

NGAL Antibody Market Size

The global NGAL Antibody market was valued at US$ 108 million in 2023 and is anticipated to reach US$ 260 million by 2030, witnessing a CAGR of 13.6% during the forecast period 2024-2030.

NGAL Antibody Market

NGAL (Neutrophil gelatinase-associated lipocalin) is a small molecule protein expressed in neutrophils and epithelial cells of some tissues and organs, including renal tubules, and is a member of the human lipocalin family. NGAL antibody, or neutrophil gelatinase-associated lipocalin antibody, is a specific antibody against neutrophil gelatinase-associated lipocalin (NGAL), and is of great value in medical research and clinical diagnosis.

North American market for NGAL Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for NGAL Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for NGAL Antibody in Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of NGAL Antibody include Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for NGAL Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGAL Antibody.

The NGAL Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGAL Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NGAL Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NGAL Antibody Market Report

Report Metric	Details
Report Name	NGAL Antibody Market
Accounted market size in 2023	US$ 108 million
Forecasted market size in 2030	US$ 260 million
CAGR	13.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Monoclonal Antibody Polyclonal Antibody
Segment by Application	Clinic Scientific Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, Bioss, BioNC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGAL Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NGAL Antibody Market growing?

Ans: The NGAL Antibody Market witnessing a CAGR of 13.6% during the forecast period 2024-2030.

What is the NGAL Antibody Market size in 2030?

Ans: The NGAL Antibody Market size in 2030 will be US$ 260 million.

Who are the main players in the NGAL Antibody Market report?

Ans: The main players in the NGAL Antibody Market are Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, Bioss, BioNC

What are the Application segmentation covered in the NGAL Antibody Market report?

Ans: The Applications covered in the NGAL Antibody Market report are Clinic, Scientific Research

What are the Type segmentation covered in the NGAL Antibody Market report?

Ans: The Types covered in the NGAL Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

Recommended Reports

Antibody Market

API and Drug

Clinical Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGAL Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibody

1.2.3 Polyclonal Antibody

1.3 Market by Application

1.3.1 Global NGAL Antibody Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinic

1.3.3 Scientific Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGAL Antibody Market Perspective (2019-2030)

2.2 Global NGAL Antibody Growth Trends by Region

2.2.1 Global NGAL Antibody Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NGAL Antibody Historic Market Size by Region (2019-2024)

2.2.3 NGAL Antibody Forecasted Market Size by Region (2025-2030)

2.3 NGAL Antibody Market Dynamics

2.3.1 NGAL Antibody Industry Trends

2.3.2 NGAL Antibody Market Drivers

2.3.3 NGAL Antibody Market Challenges

2.3.4 NGAL Antibody Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGAL Antibody Players by Revenue

3.1.1 Global Top NGAL Antibody Players by Revenue (2019-2024)

3.1.2 Global NGAL Antibody Revenue Market Share by Players (2019-2024)

3.2 Global NGAL Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by NGAL Antibody Revenue

3.4 Global NGAL Antibody Market Concentration Ratio

3.4.1 Global NGAL Antibody Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGAL Antibody Revenue in 2023

3.5 Global Key Players of NGAL Antibody Head office and Area Served

3.6 Global Key Players of NGAL Antibody, Product and Application

3.7 Global Key Players of NGAL Antibody, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NGAL Antibody Breakdown Data by Type

4.1 Global NGAL Antibody Historic Market Size by Type (2019-2024)

4.2 Global NGAL Antibody Forecasted Market Size by Type (2025-2030)

5 NGAL Antibody Breakdown Data by Application

5.1 Global NGAL Antibody Historic Market Size by Application (2019-2024)

5.2 Global NGAL Antibody Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NGAL Antibody Market Size (2019-2030)

6.2 North America NGAL Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NGAL Antibody Market Size by Country (2019-2024)

6.4 North America NGAL Antibody Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGAL Antibody Market Size (2019-2030)

7.2 Europe NGAL Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NGAL Antibody Market Size by Country (2019-2024)

7.4 Europe NGAL Antibody Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGAL Antibody Market Size (2019-2030)

8.2 Asia-Pacific NGAL Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NGAL Antibody Market Size by Region (2019-2024)

8.4 Asia-Pacific NGAL Antibody Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NGAL Antibody Market Size (2019-2030)

9.2 Latin America NGAL Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NGAL Antibody Market Size by Country (2019-2024)

9.4 Latin America NGAL Antibody Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGAL Antibody Market Size (2019-2030)

10.2 Middle East & Africa NGAL Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NGAL Antibody Market Size by Country (2019-2024)

10.4 Middle East & Africa NGAL Antibody Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific NGAL Antibody Introduction

11.1.4 Thermo Fisher Scientific Revenue in NGAL Antibody Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Abcam

11.2.1 Abcam Company Details

11.2.2 Abcam Business Overview

11.2.3 Abcam NGAL Antibody Introduction

11.2.4 Abcam Revenue in NGAL Antibody Business (2019-2024)

11.2.5 Abcam Recent Development

11.3 Hytest

11.3.1 Hytest Company Details

11.3.2 Hytest Business Overview

11.3.3 Hytest NGAL Antibody Introduction

11.3.4 Hytest Revenue in NGAL Antibody Business (2019-2024)

11.3.5 Hytest Recent Development

11.4 Enzo Life Sciences

11.4.1 Enzo Life Sciences Company Details

11.4.2 Enzo Life Sciences Business Overview

11.4.3 Enzo Life Sciences NGAL Antibody Introduction

11.4.4 Enzo Life Sciences Revenue in NGAL Antibody Business (2019-2024)

11.4.5 Enzo Life Sciences Recent Development

11.5 Biorbyt

11.5.1 Biorbyt Company Details

11.5.2 Biorbyt Business Overview

11.5.3 Biorbyt NGAL Antibody Introduction

11.5.4 Biorbyt Revenue in NGAL Antibody Business (2019-2024)

11.5.5 Biorbyt Recent Development

11.6 Proteintech

11.6.1 Proteintech Company Details

11.6.2 Proteintech Business Overview

11.6.3 Proteintech NGAL Antibody Introduction

11.6.4 Proteintech Revenue in NGAL Antibody Business (2019-2024)

11.6.5 Proteintech Recent Development

11.7 Biomatik

11.7.1 Biomatik Company Details

11.7.2 Biomatik Business Overview

11.7.3 Biomatik NGAL Antibody Introduction

11.7.4 Biomatik Revenue in NGAL Antibody Business (2019-2024)

11.7.5 Biomatik Recent Development

11.8 Bio-Techne

11.8.1 Bio-Techne Company Details

11.8.2 Bio-Techne Business Overview

11.8.3 Bio-Techne NGAL Antibody Introduction

11.8.4 Bio-Techne Revenue in NGAL Antibody Business (2019-2024)

11.8.5 Bio-Techne Recent Development

11.9 MyBioSource

11.9.1 MyBioSource Company Details

11.9.2 MyBioSource Business Overview

11.9.3 MyBioSource NGAL Antibody Introduction

11.9.4 MyBioSource Revenue in NGAL Antibody Business (2019-2024)

11.9.5 MyBioSource Recent Development

11.10 GenScript

11.10.1 GenScript Company Details

11.10.2 GenScript Business Overview

11.10.3 GenScript NGAL Antibody Introduction

11.10.4 GenScript Revenue in NGAL Antibody Business (2019-2024)

11.10.5 GenScript Recent Development

11.11 Bioss

11.11.1 Bioss Company Details

11.11.2 Bioss Business Overview

11.11.3 Bioss NGAL Antibody Introduction

11.11.4 Bioss Revenue in NGAL Antibody Business (2019-2024)

11.11.5 Bioss Recent Development

11.12 BioNC

11.12.1 BioNC Company Details

11.12.2 BioNC Business Overview

11.12.3 BioNC NGAL Antibody Introduction

11.12.4 BioNC Revenue in NGAL Antibody Business (2019-2024)

11.12.5 BioNC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Abcam

Hytest

Enzo Life Sciences

Biorbyt

Proteintech

Biomatik

Bio-Techne

MyBioSource

GenScript

Bioss

BioNC

List of Tables

Table 1. Global NGAL Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibody

Table 3. Key Players of Polyclonal Antibody

Table 4. Global NGAL Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global NGAL Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global NGAL Antibody Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global NGAL Antibody Market Share by Region (2019-2024)

Table 8. Global NGAL Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global NGAL Antibody Market Share by Region (2025-2030)

Table 10. NGAL Antibody Market Trends

Table 11. NGAL Antibody Market Drivers

Table 12. NGAL Antibody Market Challenges

Table 13. NGAL Antibody Market Restraints

Table 14. Global NGAL Antibody Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global NGAL Antibody Market Share by Players (2019-2024)

Table 16. Global Top NGAL Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGAL Antibody as of 2023)

Table 17. Ranking of Global Top NGAL Antibody Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by NGAL Antibody Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of NGAL Antibody, Headquarters and Area Served

Table 20. Global Key Players of NGAL Antibody, Product and Application

Table 21. Global Key Players of NGAL Antibody, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NGAL Antibody Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global NGAL Antibody Revenue Market Share by Type (2019-2024)

Table 25. Global NGAL Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global NGAL Antibody Revenue Market Share by Type (2025-2030)

Table 27. Global NGAL Antibody Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global NGAL Antibody Revenue Market Share by Application (2019-2024)

Table 29. Global NGAL Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global NGAL Antibody Revenue Market Share by Application (2025-2030)

Table 31. North America NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America NGAL Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America NGAL Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe NGAL Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe NGAL Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific NGAL Antibody Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific NGAL Antibody Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America NGAL Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America NGAL Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa NGAL Antibody Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa NGAL Antibody Market Size by Country (2025-2030) & (US$ Million)

Table 46. Thermo Fisher Scientific Company Details

Table 47. Thermo Fisher Scientific Business Overview

Table 48. Thermo Fisher Scientific NGAL Antibody Product

Table 49. Thermo Fisher Scientific Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 50. Thermo Fisher Scientific Recent Development

Table 51. Abcam Company Details

Table 52. Abcam Business Overview

Table 53. Abcam NGAL Antibody Product

Table 54. Abcam Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 55. Abcam Recent Development

Table 56. Hytest Company Details

Table 57. Hytest Business Overview

Table 58. Hytest NGAL Antibody Product

Table 59. Hytest Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 60. Hytest Recent Development

Table 61. Enzo Life Sciences Company Details

Table 62. Enzo Life Sciences Business Overview

Table 63. Enzo Life Sciences NGAL Antibody Product

Table 64. Enzo Life Sciences Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 65. Enzo Life Sciences Recent Development

Table 66. Biorbyt Company Details

Table 67. Biorbyt Business Overview

Table 68. Biorbyt NGAL Antibody Product

Table 69. Biorbyt Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 70. Biorbyt Recent Development

Table 71. Proteintech Company Details

Table 72. Proteintech Business Overview

Table 73. Proteintech NGAL Antibody Product

Table 74. Proteintech Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 75. Proteintech Recent Development

Table 76. Biomatik Company Details

Table 77. Biomatik Business Overview

Table 78. Biomatik NGAL Antibody Product

Table 79. Biomatik Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 80. Biomatik Recent Development

Table 81. Bio-Techne Company Details

Table 82. Bio-Techne Business Overview

Table 83. Bio-Techne NGAL Antibody Product

Table 84. Bio-Techne Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 85. Bio-Techne Recent Development

Table 86. MyBioSource Company Details

Table 87. MyBioSource Business Overview

Table 88. MyBioSource NGAL Antibody Product

Table 89. MyBioSource Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 90. MyBioSource Recent Development

Table 91. GenScript Company Details

Table 92. GenScript Business Overview

Table 93. GenScript NGAL Antibody Product

Table 94. GenScript Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 95. GenScript Recent Development

Table 96. Bioss Company Details

Table 97. Bioss Business Overview

Table 98. Bioss NGAL Antibody Product

Table 99. Bioss Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 100. Bioss Recent Development

Table 101. BioNC Company Details

Table 102. BioNC Business Overview

Table 103. BioNC NGAL Antibody Product

Table 104. BioNC Revenue in NGAL Antibody Business (2019-2024) & (US$ Million)

Table 105. BioNC Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. NGAL Antibody Picture

Figure 2. Global NGAL Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global NGAL Antibody Market Share by Type: 2023 VS 2030

Figure 4. Monoclonal Antibody Features

Figure 5. Polyclonal Antibody Features

Figure 6. Global NGAL Antibody Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global NGAL Antibody Market Share by Application: 2023 VS 2030

Figure 8. Clinic Case Studies

Figure 9. Scientific Research Case Studies

Figure 10. NGAL Antibody Report Years Considered

Figure 11. Global NGAL Antibody Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global NGAL Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global NGAL Antibody Market Share by Region: 2023 VS 2030

Figure 14. Global NGAL Antibody Market Share by Players in 2023

Figure 15. Global Top NGAL Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGAL Antibody as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by NGAL Antibody Revenue in 2023

Figure 17. North America NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America NGAL Antibody Market Share by Country (2019-2030)

Figure 19. United States NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe NGAL Antibody Market Share by Country (2019-2030)

Figure 23. Germany NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific NGAL Antibody Market Share by Region (2019-2030)

Figure 31. China NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America NGAL Antibody Market Share by Country (2019-2030)

Figure 39. Mexico NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa NGAL Antibody Market Share by Country (2019-2030)

Figure 43. Turkey NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE NGAL Antibody Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 47. Abcam Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 48. Hytest Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 49. Enzo Life Sciences Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 50. Biorbyt Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 51. Proteintech Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 52. Biomatik Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 53. Bio-Techne Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 54. MyBioSource Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 55. GenScript Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 56. Bioss Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 57. BioNC Revenue Growth Rate in NGAL Antibody Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human NGAL Test Kit Market Research Report 2024

Global Neutrophil Gelatinase associated Lipocalin Test Kit Market Research Report 2024

Global RANKL Antibody Market Research Report 2024

Global Granulocytes Antibody Market Research Report 2024

ANGPTL6 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

LC3 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global VEGFA Antibody Market Research Report 2024

Global Granulocytes Monoclonal Antibody Market Research Report 2024

Global LIGHT Antibody Market Research Report 2024

Global Bcr Abl Antibody Market Research Report 2024

Global Bcl 2 Antibody Market Research Report 2024

Global Research Grade Antibodies Market Research Report 2024

LGR5 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Lipocalin 2 NGAL ELISA Kit Market Research Report 2024

Global Lipoprotein Lipase Antibody Market Research Report 2024

Global CD25 IL2R alpha Antibody Market Research Report 2024

Global Monoclonal Antibodies for Non small Cell Lung Cancer Market Research Report 2025

Global Lipoprotein Lipase Monoclonal Antibody Market Research Report 2024

Global GITRL Antibody Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions